SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/B004869A5EB5F47F5250BA4107B34FA5E761097E8559E3F79CCC05766894C3644CDC910DA395109F31D0AA97EF9EBCFA>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/B004869A5EB5F47F5250BA4107B34FA5E761097E8559E3F79CCC05766894C3644CDC910DA395109F31D0AA97EF9EBCFA
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/B004869A5EB5F47F5250BA4107B34FA5E761097E8559E3F79CCC05766894C3644CDC910DA395109F31D0AA97EF9EBCFA
http://www.w3.org/2000/01/rdf-schema#comment
"Serum NSE may be a novel marker of disease aggressiveness as well as a prognostic factor for DLBCL in the era of rituximab."
xsd:string
http://purl.uniprot.org/uniprot/#_56838FB0A972F09ADECE3889F34EAD447B955E4E9C327843910EBC47D6931FAE7C9F2C35BC36288AB5F46A7AD4B35DF6
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/B004869A5EB5F47F5250BA4107B34FA5E761097E8559E3F79CCC05766894C3644CDC910DA395109F31D0AA97EF9EBCFA
http://purl.uniprot.org/uniprot/Q6FHV6
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/B004869A5EB5F47F5250BA4107B34FA5E761097E8559E3F79CCC05766894C3644CDC910DA395109F31D0AA97EF9EBCFA
http://purl.uniprot.org/uniprot/#_Q6FHV6-mappedCitation-21815777
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/B004869A5EB5F47F5250BA4107B34FA5E761097E8559E3F79CCC05766894C3644CDC910DA395109F31D0AA97EF9EBCFA